8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 6, 2019)

Filed August 6, 2019For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on August 6, 2019, to announce its financial results for the quarter ended June 30, 2019. This filing primarily serves to furnish a press release containing these results, which provides investors with an update on the company's operational and financial performance. While the 8-K itself does not contain detailed financial statements, it directs stakeholders to the accompanying press release for specific figures and commentary. Investors should carefully review the furnished press release (Exhibit 99.1) for the latest financial performance metrics, including revenue, net income/loss, and any commentary on the company's product pipeline and strategic developments. The information provided in this 8-K is crucial for understanding Alnylam's progress during the second quarter of 2019 and for making informed investment decisions.

Key Highlights

  • 1Alnylam Pharmaceuticals, Inc. announced its financial results for the quarter ended June 30, 2019.
  • 2The announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
  • 3This 8-K filing primarily serves to provide the market with the company's quarterly financial update.
  • 4Investors are directed to the press release for detailed financial performance and operational commentary.
  • 5The information is furnished and not deemed filed for Section 18 purposes, meaning it has limited liability implications under that specific section.
  • 6This filing is important for tracking the company's financial health and progress in the specified quarter.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Alnylam Pharmaceuticals, Inc.'s financial results for the quarter ended June 30, 2019, through an accompanying press release.

The detailed financial results and operational commentary for the quarter ended June 30, 2019, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

No, this specific 8-K filing (Item 2.02 and Item 9.01) primarily references and furnishes a press release containing the financial results. It does not include detailed financial statements directly within the 8-K text itself.

When information is 'furnished' under Item 2.02, it means it's being provided to the SEC for informational purposes but does not carry the same legal liability under Section 18 of the Exchange Act as 'filed' information. It also means it's not automatically incorporated by reference into other SEC filings unless explicitly stated.